Ashlie Arthur, DO Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1265 Highway 54 W Ste 500a, Fayetteville, GA 30214 Phone: 770-506-1500 |
Anjali Harish Patel, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1265 Highway 54 W Ste 500a, Fayetteville, GA 30214 Phone: 770-506-1500 |
Rahim Wooley, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1265 Highway 54 W Ste 500a, Fayetteville, GA 30214 Phone: 770-716-0051 |
News Archive
Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy. Treatment with afatinib significantly reduced the risk of death by 19%, extending the survival of patients to a median of 7.9 months compared to 6.8 months on erlotinib.
Drug resistant bacteria are fast becoming one of the big worries of the 21 century. Now researchers at the University of Copenhagen have discovered a previously unknown weakness; an "Achilles heel", of bacteria. Their discovery, a crucial step in bacteria's energy metabolism, may be the first step in developing an entirely novel form of antibiotics
Gastritis produced by acetyl-salicylic acid consumption is a common disorder worldwide. The use of probiotics has been proposed to ameliorate different gastrointestinal tract diseases such as inflammatory bowel disease, diarrhea, irritable bowel syndrome, etc. However, little attention has been paid to the use of probiotics in gastric disease.
New types of drug intended for use in place of antibiotics have been given a cautious welcome by scientists.
Researchers at Tokyo Institute of Technology have identified an enzyme that controls how much our cells secrete collagen.
› Verified 7 days ago